Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
120.50
-1.47 (-1.21%)
At close: Mar 25, 2025, 4:00 PM
120.51
+0.01 (0.01%)
After-hours: Mar 25, 2025, 4:53 PM EST
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.68B in the quarter ending January 31, 2025, with 1.39% growth. This brings the company's revenue in the last twelve months to $6.53B, down -3.00% year-over-year. In the fiscal year ending October 31, 2024, Agilent Technologies had annual revenue of $6.51B, down -4.73%.
Revenue (ttm)
$6.53B
Revenue Growth
-3.00%
P/S Ratio
5.31
Revenue / Employee
$364,972
Employees
17,900
Market Cap
34.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
Oct 31, 2019 | Pro | Pro | Pro |
Oct 31, 2018 | Pro | Pro | Pro |
Oct 31, 2017 | Pro | Pro | Pro |
Oct 31, 2016 | Pro | Pro | Pro |
Oct 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
A News
- 1 day ago - Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval - Business Wire
- 5 days ago - CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025 - Business Wire
- 5 days ago - Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025 - Business Wire
- 6 days ago - Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski - Business Wire
- 15 days ago - Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications - Business Wire
- 21 days ago - Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript) - Seeking Alpha
- 24 days ago - Agilent Technologies: Recent Price Weakness Makes This Stock A Buy - Seeking Alpha
- 25 days ago - Agilent to Participate in TD Cowen Health Care Conference - Business Wire